A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Cell research - 28(2018), 6 vom: 05. Juni, Seite 690-692 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Cun [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CDK7 protein, human |
|---|
| Anmerkungen: |
Date Completed 30.09.2019 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41422-018-0020-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM281644209 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM281644209 | ||
| 003 | DE-627 | ||
| 005 | 20231225032115.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41422-018-0020-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0938.xml |
| 035 | |a (DE-627)NLM281644209 | ||
| 035 | |a (NLM)29507396 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Cun |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.09.2019 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a MYC protein, human |2 NLM | |
| 650 | 7 | |a Proto-Oncogene Proteins c-myc |2 NLM | |
| 650 | 7 | |a Cyclin-Dependent Kinases |2 NLM | |
| 650 | 7 | |a EC 2.7.11.22 |2 NLM | |
| 650 | 7 | |a Cyclin-Dependent Kinase-Activating Kinase |2 NLM | |
| 650 | 7 | |a EC 2.7.11.22 |2 NLM | |
| 650 | 7 | |a CDK7 protein, human |2 NLM | |
| 700 | 1 | |a Jin, Haojie |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Dongmei |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Liqin |e verfasserin |4 aut | |
| 700 | 1 | |a Evers, Bastiaan |e verfasserin |4 aut | |
| 700 | 1 | |a Xue, Zheng |e verfasserin |4 aut | |
| 700 | 1 | |a Jin, Guangzhi |e verfasserin |4 aut | |
| 700 | 1 | |a Lieftink, Cor |e verfasserin |4 aut | |
| 700 | 1 | |a Beijersbergen, Roderick L |e verfasserin |4 aut | |
| 700 | 1 | |a Qin, Wenxin |e verfasserin |4 aut | |
| 700 | 1 | |a Bernards, René |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell research |d 1997 |g 28(2018), 6 vom: 05. Juni, Seite 690-692 |w (DE-627)NLM09215381X |x 1748-7838 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2018 |g number:6 |g day:05 |g month:06 |g pages:690-692 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41422-018-0020-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2018 |e 6 |b 05 |c 06 |h 690-692 | ||